Key to any decision making process whether it be regarding investment, divestment, acquisition or related transactions is independent advice regarding technology, deal shape, management, business content and value.
Sage has undertaken many such transactions to provide an independent assessment of deals from the standpoint of both due diligence and technology assessment.
Our work has been conducted for clients from both private and public company environments, and for funding bodies including venture capital, institutional and diverse private equity sources.
Due diligence at this level can prove very cost effective in terms of recognising issues which may affect the value and validity of the transaction, and identify areas which will have long term impact on the value of any deal.
Technology Assessment
Technology assessment is also key to most healthcare companies and Sage is well placed to undertake assignments which seek to understand issues fundamental to company value in businesses which encompass:
- Pharmaceuticals
- Biotechnology
- Diagnostics
- Medical Devices & Medical Technology
- Medical Bioinformatics
- Healthcare
- Animal Health & Veterinary Science
- Nutraceuticals and Food
Valuations
Sage has routinely assisted companies and investors with company valuations for purposes ranging from investment to divestment to share option schemes. We employ a variety of methodologies, including both industry standard approaches as well as our own internal approaches. In addition, we employ extensive research to identify deal comparables relevant to each individual situation. |  | |